Brand: MSD

Equilis Te Suspension for Injection for Horses

Name: Equilis Te Suspension for Injection for Horses
Availability: OutOfStock

£98.99

Equilis Te suspension for injection for horses is used to immunise horses against tetanus

Legal Category : POM-V

This product requires a valid veterinary prescription for purchase

Out of stock

View POM

Delivery & Returns

Secure Checkout with

Accredited Retailer

Equilis Te is used for active immunisation of horses from 6 months of age against tetanus to prevent mortality.

Onset of immunity:	2 weeks after the primary vaccination course
Duration of immunity:	17 months after the primary vaccination course
	2 years after the first revaccination

Amounts to be administered and administration route

Intramuscular use.

Allow the vaccine to reach room temperature before use.

Vaccination schedule: Primary vaccination course Administer one dose (1ml), by intramuscular injection, according to the following schedule:

Primary vaccination course: first injection from 6 months of age, second injection 4 weeks later.

Revaccination:The first revaccination is given not later than 17 months after the primary vaccination course. Thereafter a maximum interval of two years is recommended (see schedule).

V1	V2	5		12	V3	24	V4
0	1		6		18		42 months
Equilis Te	Equilis Te				Equilis Te		Equilis Te

In case of increased infection risk or insufficient colostrum intake, an additional initial injection can be given at the age of 4 months followed by the full vaccination programme (primary vaccination course at 6 months of age and 4 weeks later)

Concurrent active and passive immunisation (emergency vaccination)

The vaccine can be used together with Tetanus Antitoxin Behring for treatment of injured horses that have not been immunised against tetanus. In that case, the first dose (V1) of vaccine can be given concurrently with the appropriate prophylactic dose of Tetanus Antitoxin Behring at a separate injection site, using separate syringes and needles. This will lead to a passive protection against tetanus for at least 21 days after concurrent administration. The second dose of the vaccine (V2) should be administered 4 weeks later. A third vaccination with Equilis Te should be repeated at least four weeks later. Concurrent use of Equilis Te and Tetanus Antitoxin Behring may reduce active immunity against tetanus compared to horses vaccinated with Equilis Te in the absence of tetanus antitoxin serum.

Product Description

Equilis Te is used for active immunisation of horses from 6 months of age against tetanus to prevent mortality.

Onset of immunity:	2 weeks after the primary vaccination course
Duration of immunity:	17 months after the primary vaccination course
	2 years after the first revaccination

Amounts to be administered and administration route

Intramuscular use.

Allow the vaccine to reach room temperature before use.

Vaccination schedule: Primary vaccination course Administer one dose (1ml), by intramuscular injection, according to the following schedule:

Primary vaccination course: first injection from 6 months of age, second injection 4 weeks later.
Revaccination:The first revaccination is given not later than 17 months after the primary vaccination course. Thereafter a maximum interval of two years is recommended (see schedule).

V1	V2	5		12	V3	24	V4
0	1		6		18		42 months
Equilis Te	Equilis Te				Equilis Te		Equilis Te

In case of increased infection risk or insufficient colostrum intake, an additional initial injection can be given at the age of 4 months followed by the full vaccination programme (primary vaccination course at 6 months of age and 4 weeks later)

Concurrent active and passive immunisation (emergency vaccination)

The vaccine can be used together with Tetanus Antitoxin Behring for treatment of injured horses that have not been immunised against tetanus. In that case, the first dose (V1) of vaccine can be given concurrently with the appropriate prophylactic dose of Tetanus Antitoxin Behring at a separate injection site, using separate syringes and needles. This will lead to a passive protection against tetanus for at least 21 days after concurrent administration. The second dose of the vaccine (V2) should be administered 4 weeks later. A third vaccination with Equilis Te should be repeated at least four weeks later. Concurrent use of Equilis Te and Tetanus Antitoxin Behring may reduce active immunity against tetanus compared to horses vaccinated with Equilis Te in the absence of tetanus antitoxin serum.

About the Brand